CSIR To Assess Efficacy Of Gout Drug 'Colchicine' For Covid-19 Treatment, Receives DCGI Approval
Colchicine is expected to be an important therapeutic intervention for Covid-19 patients with cardiac co-morbidities. But the RECOVERY trial has already closed recruitment to colchicine treatment arm.




